David A. Fiellin, MD

COVID-19–driven telehealth exposure positively shifted physician respondents’ perceptions of telehealth effectiveness, and most are likely to continue use if temporary telehealth regulatory flexibility is permanently extended.

Federal parity led to an increase in spending on substance use disorder treatment.